Note: This is an edited excerpt. Listen to the full podcast episode here.
Question: What are your best opportunities for growth over the next year or two?
Mr. Figueroa: Something we’re really excited about, that we’ve been hoping to launch soon, is an ovarian tissue cryopreservation and transplantation program. [It] would basically allow us to take, for example, prepubescent cancer patients and be able to harvest ovarian tissue or the entire ovary [and] cryopreserve it.
[The patient would] then go through their cancer treatment, which would otherwise typically destroy the ovary,and [once] they’ve gone into a remission state, we re-transplant that ovary or that tissue back into the patient so that they can have a family.
It’s something that has been, up until the last year or so, fairly experimental. We actually had a team from Denmark come in and help train and set up some of our equipment and go through some of those procedures with our doctors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
